XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.3
FAIR VALUE DISCLOSURES OF FINANCIAL ASSETS AND LIABILITIES (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Carried at Fair Value
The following tables present financial instruments carried at fair value as of September 30, 2023 and December 31, 2022 by level in the valuation hierarchy (as described above):
September 30, 2023
(Dollars in thousands)Quoted
Prices in
Active
Markets for
Identical
Asset
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total Fair
Value
Assets measured at fair value on a recurring basis:
Available-for-sale securities:
CMO$— $454,664 $— $454,664 
FNMA MBS— 2,913,412 — 2,913,412 
FHLMC MBS— 110,719 — 110,719 
GNMA MBS— 42,751 — 42,751 
GSE agency notes— 169,995 — 169,995 
Other assets— 203,083 23 203,106 
Total assets measured at fair value on a recurring basis$— $3,894,624 $23 $3,894,647 
Liabilities measured at fair value on a recurring basis:
Other liabilities$— $196,821 $14,482 $211,303 
Assets measured at fair value on a nonrecurring basis:
Other investments$— $— $21,741 $21,741 
Other real estate owned— — 298 298 
Loans held for sale— 36,658 — 36,658 
Total assets measured at fair value on a nonrecurring basis$— $36,658 $22,039 $58,697 
December 31, 2022
(Dollars in thousands)Quoted
Prices in
Active
Markets for
Identical
Asset
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total Fair
Value
Assets measured at fair value on a recurring basis:
Available-for-sale securities:
CMO$— $506,380 $— $506,380 
FNMA MBS— 3,250,258 — 3,250,258 
FHLMC MBS— 121,999 — 121,999 
GNMA MBS— 36,138 — 36,138 
GSE agency notes— 178,285 — 178,285 
Other assets— 156,912 81 156,993 
Total assets measured at fair value on a recurring basis$— $4,249,972 $81 $4,250,053 
Liabilities measured at fair value on a recurring basis:
Other liabilities$— $156,520 $17,102 $173,622 
Assets measured at fair value on a nonrecurring basis
Other investments$— $— $26,120 $26,120 
Other real estate owned— — 833 833 
Loans held for sale— 42,985 — 42,985 
Total assets measured at fair value on a nonrecurring basis$— $42,985 $26,953 $69,938 
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The following tables provide a description of the valuation techniques and significant unobservable inputs for the Company's financial instruments classified as Level 3 as of September 30, 2023 and December 31, 2022:
(Dollars in thousands)September 30, 2023
Financial InstrumentFair ValueValuation Technique(s)Unobservable InputRange
(Weighted Average)
Other investments$21,741 Observed market comparable transactionsPeriod of observed transactions
May 2022
Other real estate owned298 Fair market value of collateralCosts to sell
10.0%
Other assets (Risk participation agreements purchased)23
Credit Value Adjustment
CDS Spread and Loss Given Default (LGD)
CDS spread: 110 - 360 bps (196 bps)
LGD: –% - 30% (30%)
Other liabilities (Risk participation agreements sold)1 
Credit Value Adjustment
CDS Spread and Loss Given Default (LGD)
CDS spread: 1 - 250 bps (78 bps)
LGD: 30%
Other liabilities (Financial derivative related to
sales of certain Visa Class B shares)		14,481 Discounted cash flowTiming of Visa litigation resolution
1.00 - 5.00 years (3.20 years or 4Q 2025)
(Dollars in thousands)December 31, 2022
Financial InstrumentFair ValueValuation Technique(s)Unobservable InputRange
(Weighted Average)
Other investments$26,120 Observed market comparable transactionsPeriod of observed transactionsMay 2022
Other real estate owned833 Fair market value of collateralCosts to sell
10.0%
Other assets (Risk participation agreements purchased)81
Credit Value Adjustment
CDS Spread and Loss Given Default (LGD)
CDS spread: 110 - 250 bps (205 bps)
LGD: –% - 30% (30%)
Other liabilities (Risk participation agreements sold)2 
Credit Value Adjustment
CDS Spread and Loss Given Default (LGD)
CDS spread: 1 - 250 bps (158 bps)
LGD: 30%
Other liabilities (Financial derivative related to
sales of certain Visa Class B shares)		17,100 Discounted cash flowTiming of Visa litigation resolution
1.00 - 5.75 years (3.61 years or 4Q 2025)
Schedule of Book Value and Estimated Fair Value of Financial Instruments
The book value and estimated fair value of the Company's financial instruments are as follows:
 
September 30, 2023December 31, 2022
(Dollars in thousands)Fair Value
Measurement		Book ValueFair ValueBook ValueFair Value
Financial assets:
Cash, cash equivalents, and restricted cashLevel 1$611,480 $611,480 $837,258 $837,258 
Investment securities available-for-saleLevel 23,691,541 3,691,541 4,093,060 4,093,060 
Investment securities held-to-maturity, netLevel 21,068,871 927,680 1,111,619 1,040,104 
Other investmentsLevel 321,741 21,741 26,120 26,120 
Loans, held for saleLevel 236,658 36,658 42,985 42,985 
Loans and leases, net(1)
Level 312,502,404 12,454,772 11,759,992 11,567,888 
Stock in FHLB of PittsburghLevel 212,199 12,199 24,116 24,116 
Accrued interest receivableLevel 281,909 81,909 74,448 74,448 
Other assetsLevels 2, 3203,106 203,106 156,993 156,993 
Financial liabilities:
DepositsLevel 2$15,986,369 $15,951,775 $16,203,569 $16,156,124 
Borrowed fundsLevel 2917,833 917,053 726,894 709,014 
Standby letters of credit
Level 3663 663 739 739 
Accrued interest payableLevel 242,481 42,481 5,174 5,174 
Other liabilitiesLevels 2, 3211,303 211,303 173,622 173,622 
 (1) Includes reverse mortgage loans.